Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide (Q40541643)
Jump to navigation
Jump to search
scientific article published on June 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide |
scientific article published on June 2004 |
Statements
1 reference
Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide (English)
1 reference
Christiane Thallinger
1 reference
Markus F Wolschek
1 reference
Helmut Maierhofer
1 reference
Hans Skvara
1 reference
Hubert Pehamberger
1 reference
Brett P Monia
1 reference
Burkhard Jansen
1 reference
Volker Wacheck
1 reference
Edgar Selzer
1 reference
1 June 2004
1 reference
1 reference
Identifiers
1 reference